Session Details

[1AS2-07]【J】Ethics and Governance of High-Risk Microbiological Research

Tue. Dec 1, 2026 11:15 AM - 12:45 PM JST
Tue. Dec 1, 2026 2:15 AM - 3:45 AM UTC
Room 7 (Conference Center 3F 313+314)
Organizers: Hideki Kakeya (University of Tsukuba), Takeshi Nitta (Tokyo University of Science)
In the aftermath of the COVID-19 pandemic, discussions in the United States have focused on strengthening oversight of high-risk research, including pathogen-related gain-of-function studies. At the same time, research on engineered pathogens that may constitute dual-use research of concern (DURC) underscores the limitations of regulation within a single jurisdiction and raises concerns about the relocation of research to settings with weaker oversight and ethical frameworks. Moreover, awareness that many life scientists are themselves stakeholders in high-risk microbiological research, as well as recognition that norms governing biosafety and bioethics evolve over time, are not always widely shared. This symposium will examine these challenges, with a focus on biosafety and biosecurity risk management, transparency and accountability, and the development of internationally shared norms and governance arrangements.

Introduction

[1AS2-07-01]Beyond Dual-Use: Biotechnology, AI, and Biosecurity Governance in the Omni-Use Era

○Kiwako Tanaka1 (1. Toyo Eiwa University)
Comment()

[1AS2-07-02]Current status and challenges of dual-use microbial research of concern

○Nariyoshi Shinomiya1 (1. Japan Institute for Health Security)
Comment()

[1AS2-07-03]Are Virologists Above the Law?

○Testuya Toyoda1 (1. Fukushimura Hospital)
Comment()

General Discussion